Browsing by Author Weinmann, Arndt

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 18 of 18
PreviewIssue dateOnline publication dateTitleAuthor(s)
baseline_splenic_volume_outwe-20230119103743062.pdf.jpg202220-Jan-2023Baseline splenic volume outweighs immuno-modulated size changes with regard to survival outcome in patients with hepatocellular carcinoma under immunotherapyMüller, Lukas; Gairing, Simon Johannes; Kloeckner, Roman; Foerster, Friedrich; Weinmann, Arndt; Mittler, Jens; Stoehr, Fabian; Emrich, Tilman; Düber, Christoph; Galle, Peter Robert; Hahn, Felix
comprehensive_clinicopatholog-20220902141107519.pdf.jpg20225-Sep-2022Comprehensive clinicopathologic study of alpha fetoprotein-expression in a large cohort of patients with hepatocellular carcinomaRidder, Dirk Andreas; Weinmann, Arndt; Schindeldecker, Mario; Urbansky, Lana Louisa; Berndt, Kristina; Gerber, Tiemo Sven; Lang, Hauke; Lotz, Johannes; Lackner, Karl J.; Roth, Wilfried; Straub, Beate Katharina
conventional_transarterial_ch-20220714110410526.pdf.jpg201515-Jul-2022Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinomaKlöckner, Roman; Weinmann, Arndt; Prinz, Friederike; Pinto dos Santos, Daniel; Ruckes, Christian; Düber, Christoph; Pitton, Michael Bernhard
cost_evaluation_of_pageb_risk-20220630121855371.pdf.jpg202130-Jun-2022Cost evaluation of PAGE-B risk score guided HCC surveillance in patients with treated chronic hepatitis BSprinzl, Martin F.; Feist, Christina; Koch, Sandra; Kremer, Wolfgang Maximilian; Lackner, Karl J.; Weinmann, Arndt; Galle, Peter R.
fully_automated_aibased_splen-20221114113932032.pdf.jpg202220-Dec-2022Fully automated AI-based splenic segmentation for predicting survival and estimating the risk of hepatic decompensation in TACE patients with HCCMüller, Lukas; Kloeckner, Roman; Mähringer-Kunz, Aline; Stoehr, Fabian; Düber, Christoph; Arnhold, Gordon; Gairing, Simon Johannes; Foerster, Friedrich; Weinmann, Arndt; Galle, Peter Robert; Mittler, Jens; Pinto dos Santos, Daniel; Hahn, Felix
immunoadsorption_and_plasma_e-20220902142518221.pdf.jpg20225-Sep-2022Immunoadsorption and plasma exchange : efficient treatment options for neurological autoimmune diseasesBoedecker, Simone C.; Luessi, Felix; Engel, Sinah; Kraus, Daniel; Klimpke, Pascal; Holtz, Stefan; Meinek, Myriam; Marczynski, Paul; Weinmann, Arndt; Weinmann-Menke, Julia
nonbacterial_thrombotic_endoc-20220905103259854.pdf.jpg202112-Sep-2022Non-bacterial thrombotic endocarditis in a patient with pancreatic carcinomaWild, Johannes; Distelmeier, Simon; Keil, Philip; Weinmann, Arndt; Münzel, Thomas; Weinmann-Menke, Julia; Kraus, Daniel
mähringer-kunz_aline-predicting_sur-20210826101204684.pdf.jpg202026-Aug-2021Predicting survival after transarterial chemoembolization for hepatocellular carcinoma using a neural network : a pilot studyMähringer-Kunz, Aline; Wagner, Franziska; Hahn, Felix; Weinmann, Arndt; Brodehl, Sebastian; Schotten, Sebastian; Hinrichs, Jan B.; Düber, Christoph; Galle, Peter R.; Pinto dos Santos, Daniel; Kloeckner, Roman
prevalence_and_clinical_signi-20221201094912961.pdf.jpg20221-Dec-2022Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolizationMüller, Lukas; Hahn, Felix; Mähringer-Kunz, Aline; Stoehr, Fabian; Gairing, Simon Johannes; Foerster, Friedrich; Weinmann, Arndt; Galle, Peter R.; Mittler, Jens; Pinto dos Santos, Daniel; Pitton, Michael Bernhard; Düber, Christoph; Fehrenbach, Uli; Auer, Timo Alexander; Gebauer, Bernhard; Kloeckner, Roman
quantitative_assessment_of_wa-20220712210452927.pdf.jpg201614-Jul-2022Quantitative assessment of washout in hepatocellular carcinoma using MRIKlöckner, Roman; Pinto dos Santos, Daniel; Kreitner, Karl-Friedrich; Leicher-Düber, Anne; Weinmann, Arndt; Mittler, Jens; Düber, Christoph
59893.pdf.jpg202030-Jun-2020Risk prediction in intrahepatic cholangiocarcinoma : direct comparison of the MEGNA score and the 8th edition of the UICC/AJCC cancer staging systemHahn, Felix; Müller, Lukas; Mähringer-Kunz, Aline; Schotten, Sebastian; Düber, Christoph; Hinrichs, Jan B.; Maschke, Sabine K.; Galle, Peter R.; Bartsch, Fabian; Lang, Hauke; Weinmann, Arndt; Kloeckner, Roman
hahn_felix-risk_stratific-20201015161959392.pdf.jpg202016-Oct-2020Risk stratification in advanced biliary tract cancer : validation of the A.L.A.N. scoreMüller, Lukas; Mähringer-Kunz, Aline; Jungmann, Florian; Tanyildizi, Yasemin; Bartsch, Fabian; Czauderna, Carolin; Düber, Christoph; Galle, Peter R.; Weinmann, Arndt; Kloeckner, Roman; Hahn, Felix
selective_internal_radiothera-20220914234950293.pdf.jpg20146-Oct-2022Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC) : study protocol for a randomized controlled trialKlöckner, Roman; Ruckes, Christian; Kronfeld, Kai; Wörns, Marcus-Alexander; Weinmann, Arndt; Galle, Peter R.; Lang, Hauke; Otto, Gerd; Eichhorn, Waltraud; Schreckenberger, Mathias; Düber, Christoph; Pitton, Michael B.
sonographic_assessment_of_low-20221206094630446.pdf.jpg20226-Dec-2022Sonographic assessment of low muscle quantity identifies mortality risk during COVID-19 : a prospective single-centre studyKremer, Wolfgang M.; Labenz, Christian; Kuchen, Robert; Sagoschen, Ingo; Bodenstein, Marc; Schreiner, Oliver; Wörns, Marcus-Alexander; Sivanathan, Visvakanth; Weinmann, Arndt; Galle, Peter R.; Sprinzi, Martin F.
kloeckner_roman-survival_predi-20210416121106975.pdf.jpg20203-May-2021Survival prediction for patients with non-resectable intrahepatic cholangiocarcinoma undergoing chemotherapy : a retrospective analysis comparing the tumor marker CA 19-9 with cross-sectional imagingHahn, Felix; Müller, Lukas; Jungmann, Florian; Mähringer‑Kunz, Aline; Tanyildizi, Yasemin; Düber, Christoph; Galle, Peter R.; Weinmann, Arndt; Kloeckner, Roman
transforming_growth_factor_ac-20220628133848824.pdf.jpg202213-Jan-2023Transforming growth factor-β activated kinase 1 (Tak1) is activated in hepatocellular carcinoma, mediates tumor progression, and predicts unfavorable outcomeRidder, Dirk Andreas; Urbansky, Lana Louisa; Witzel, Hagen Roland; Schindeldecker, Mario; Weinmann, Arndt; Berndt, Kristina; Gerber, Tiemo Sven; Köhler, Bruno Christian; Nichetti, Federico; Ludt, Annekathrin; Gehrke, Nadine; Schattenberg, Jörn Markus; Heinrich, Stefan; Roth, Wilfried; Straub, Beate Katharina
transjugular_portosystemic_st-20220822160202310.pdf.jpg202224-Aug-2022Transjugular portosystemic stent shunt : impact of right atrial pressure on portal venous hemodynamics within the first weekPitton, Michael Bernhard; Weinmann, Arndt; Klockner, Roman; Mittler, Jens; Ruckes, Christian; Düber, Christoph; Otto, Gerd
58506.pdf.jpg201817-Oct-2018Validation of the SNACOR clinical scoring system after transarterial chemoembolisation in patients with hepatocellular carcinomaMähringer-Kunz, Aline; Weinmann, Arndt; Schmidtmann, Irene; Koch, Sandra; Schotten, Sebastian; Pinto dos Santos, Daniel; Pitton, Michael B.; Düber, Christoph; Galle, Peter R.; Klöckner, Roman